Novel Noninvasive Paraclinical Study Method for Investigation of Liver Diseases

Biomedicines. 2023 Sep 3;11(9):2449. doi: 10.3390/biomedicines11092449.

Abstract

Based on a prior university patent, the authors developed a novel type of bioimpedance-based test method to noninvasively detect nonalcoholic fatty liver disease (NAFLD). The development of a new potential NAFLD diagnostic procedure may help to understand the underlying mechanisms between NAFLD and severe liver diseases with a painless and easy-to-use paraclinical examination method, including the additional function to detect even the earlier stages of liver disease. The aim of this study is to present new results and the experiences gathered in relation to NAFLD progress during animal model and human clinical trials.

Keywords: NAFLD; Wistar; bioelectrical impedance spectroscopy; clinical study; hepatic steatosis; low-frequency measurement; noninvasive measurement; validation.